<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d532" origId="Ertapenem"><sentence id="DrugDDI.d532.s0" origId="s0" text="When ertapenem is co-administered with probenecid (500 mg p.o. every 6 hours), probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem."><entity charOffset="5-14" id="DrugDDI.d532.s0.e0" origId="s0.p1" text="ertapenem" type="drug"/><entity charOffset="39-49" id="DrugDDI.d532.s0.e1" origId="s0.p4" text="probenecid" type="drug"/><entity charOffset="51-55" id="DrugDDI.d532.s0.e2" origId="s0.p6" text="500" type="drug"/><entity charOffset="79-89" id="DrugDDI.d532.s0.e3" origId="s0.p9" text="probenecid" type="drug"/><entity charOffset="163-172" id="DrugDDI.d532.s0.e4" origId="s0.p14" text="ertapenem" type="drug"/><pair e1="DrugDDI.d532.s0.e0" e2="DrugDDI.d532.s0.e1" id="DrugDDI.d532.s0.p0" interaction="true"/><pair e1="DrugDDI.d532.s0.e0" e2="DrugDDI.d532.s0.e2" id="DrugDDI.d532.s0.p1" interaction="false"/><pair e1="DrugDDI.d532.s0.e0" e2="DrugDDI.d532.s0.e3" id="DrugDDI.d532.s0.p2" interaction="false"/><pair e1="DrugDDI.d532.s0.e0" e2="DrugDDI.d532.s0.e4" id="DrugDDI.d532.s0.p3" interaction="false"/><pair e1="DrugDDI.d532.s0.e1" e2="DrugDDI.d532.s0.e2" id="DrugDDI.d532.s0.p4" interaction="false"/><pair e1="DrugDDI.d532.s0.e1" e2="DrugDDI.d532.s0.e3" id="DrugDDI.d532.s0.p5" interaction="false"/><pair e1="DrugDDI.d532.s0.e1" e2="DrugDDI.d532.s0.e4" id="DrugDDI.d532.s0.p6" interaction="false"/><pair e1="DrugDDI.d532.s0.e2" e2="DrugDDI.d532.s0.e3" id="DrugDDI.d532.s0.p7" interaction="false"/><pair e1="DrugDDI.d532.s0.e2" e2="DrugDDI.d532.s0.e4" id="DrugDDI.d532.s0.p8" interaction="false"/><pair e1="DrugDDI.d532.s0.e3" e2="DrugDDI.d532.s0.e4" id="DrugDDI.d532.s0.p9" interaction="false"/></sentence><sentence id="DrugDDI.d532.s1" origId="s1" text="Based on total ertapenem concentrations, probenecid increased the AUC by 25% and reduced the plasma and renal clearances by 20% and 35%, respectively."><entity charOffset="15-24" id="DrugDDI.d532.s1.e0" origId="s1.p16" text="ertapenem" type="drug"/><entity charOffset="41-51" id="DrugDDI.d532.s1.e1" origId="s1.p17" text="probenecid" type="drug"/><pair e1="DrugDDI.d532.s1.e0" e2="DrugDDI.d532.s1.e1" id="DrugDDI.d532.s1.p0" interaction="true"/></sentence><sentence id="DrugDDI.d532.s2" origId="s2" text="The half-life increased from 4.0 to 4.8 hours."/><sentence id="DrugDDI.d532.s3" origId="s3" text="Because of the small effect on half-life, the coadministration with probenecid to extend the half-life of ertapenem is not recommended."><entity charOffset="68-78" id="DrugDDI.d532.s3.e0" origId="s3.p37" text="probenecid" type="drug"/><entity charOffset="106-115" id="DrugDDI.d532.s3.e1" origId="s3.p40" text="ertapenem" type="drug"/><pair e1="DrugDDI.d532.s3.e0" e2="DrugDDI.d532.s3.e1" id="DrugDDI.d532.s3.p0" interaction="true"/><negationtags>Because of the small effect on half-life, &lt;xcope&gt;the coadministration with probenecid to extend the half-life of ertapenem is &lt;cue&gt;not&lt;/cue&gt; recommended&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d532.s4" origId="s4" text="In vitro studies indicate that ertapenem does not inhibit P-glycoprotein-mediated transport of digoxin or vinblastine and that ertapenem is not a substrate for P-glycoprotein-mediated transport."><entity charOffset="31-40" id="DrugDDI.d532.s4.e0" origId="s4.p46" text="ertapenem" type="drug"/><entity charOffset="60-72" id="DrugDDI.d532.s4.e1" origId="s4.p50" text="glycoprotein" type="drug"/><entity charOffset="95-102" id="DrugDDI.d532.s4.e2" origId="s4.p51" text="digoxin" type="drug"/><entity charOffset="106-117" id="DrugDDI.d532.s4.e3" origId="s4.p53" text="vinblastine" type="drug"/><entity charOffset="127-136" id="DrugDDI.d532.s4.e4" origId="s4.p55" text="ertapenem" type="drug"/><entity charOffset="162-174" id="DrugDDI.d532.s4.e5" origId="s4.p58" text="glycoprotein" type="drug"/><pair e1="DrugDDI.d532.s4.e0" e2="DrugDDI.d532.s4.e1" id="DrugDDI.d532.s4.p0" interaction="false"/><pair e1="DrugDDI.d532.s4.e0" e2="DrugDDI.d532.s4.e2" id="DrugDDI.d532.s4.p1" interaction="false"/><pair e1="DrugDDI.d532.s4.e0" e2="DrugDDI.d532.s4.e3" id="DrugDDI.d532.s4.p2" interaction="false"/><pair e1="DrugDDI.d532.s4.e0" e2="DrugDDI.d532.s4.e4" id="DrugDDI.d532.s4.p3" interaction="false"/><pair e1="DrugDDI.d532.s4.e0" e2="DrugDDI.d532.s4.e5" id="DrugDDI.d532.s4.p4" interaction="false"/><pair e1="DrugDDI.d532.s4.e1" e2="DrugDDI.d532.s4.e2" id="DrugDDI.d532.s4.p5" interaction="false"/><pair e1="DrugDDI.d532.s4.e1" e2="DrugDDI.d532.s4.e3" id="DrugDDI.d532.s4.p6" interaction="false"/><pair e1="DrugDDI.d532.s4.e1" e2="DrugDDI.d532.s4.e4" id="DrugDDI.d532.s4.p7" interaction="false"/><pair e1="DrugDDI.d532.s4.e1" e2="DrugDDI.d532.s4.e5" id="DrugDDI.d532.s4.p8" interaction="false"/><pair e1="DrugDDI.d532.s4.e2" e2="DrugDDI.d532.s4.e3" id="DrugDDI.d532.s4.p9" interaction="false"/><pair e1="DrugDDI.d532.s4.e2" e2="DrugDDI.d532.s4.e4" id="DrugDDI.d532.s4.p10" interaction="false"/><pair e1="DrugDDI.d532.s4.e2" e2="DrugDDI.d532.s4.e5" id="DrugDDI.d532.s4.p11" interaction="false"/><pair e1="DrugDDI.d532.s4.e3" e2="DrugDDI.d532.s4.e4" id="DrugDDI.d532.s4.p12" interaction="false"/><pair e1="DrugDDI.d532.s4.e3" e2="DrugDDI.d532.s4.e5" id="DrugDDI.d532.s4.p13" interaction="false"/><pair e1="DrugDDI.d532.s4.e4" e2="DrugDDI.d532.s4.e5" id="DrugDDI.d532.s4.p14" interaction="false"/><negationtags>In vitro studies indicate that ertapenem does &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; inhibit P-glycoprotein-mediated transport of digoxin or vinblastine&lt;/xcope&gt; and that ertapenem is &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; a substrate for P-glycoprotein-mediated transport&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d532.s5" origId="s5" text="In vitro studies in human liver microsomes indicate that ertapenem does not inhibit metabolism mediated by any of the following six cytochrome p450 (CYP) isoforms: 1A2, 2C9, 2C19, 2D6, 2E1 and 3A4."><entity charOffset="57-66" id="DrugDDI.d532.s5.e0" origId="s5.p62" text="ertapenem" type="drug"/><entity charOffset="132-147" id="DrugDDI.d532.s5.e1" origId="s5.p69" text="cytochrome p450" type="drug"/><entity charOffset="149-152" id="DrugDDI.d532.s5.e2" origId="s5.p71" text="CYP" type="drug"/><entity charOffset="154-162" id="DrugDDI.d532.s5.e3" origId="s5.p73" text="isoforms" type="drug"/><pair e1="DrugDDI.d532.s5.e0" e2="DrugDDI.d532.s5.e1" id="DrugDDI.d532.s5.p0" interaction="false"/><pair e1="DrugDDI.d532.s5.e0" e2="DrugDDI.d532.s5.e2" id="DrugDDI.d532.s5.p1" interaction="false"/><pair e1="DrugDDI.d532.s5.e0" e2="DrugDDI.d532.s5.e3" id="DrugDDI.d532.s5.p2" interaction="false"/><pair e1="DrugDDI.d532.s5.e1" e2="DrugDDI.d532.s5.e2" id="DrugDDI.d532.s5.p3" interaction="false"/><pair e1="DrugDDI.d532.s5.e1" e2="DrugDDI.d532.s5.e3" id="DrugDDI.d532.s5.p4" interaction="false"/><pair e1="DrugDDI.d532.s5.e2" e2="DrugDDI.d532.s5.e3" id="DrugDDI.d532.s5.p5" interaction="false"/><negationtags>In vitro studies in human liver microsomes indicate that ertapenem does &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; inhibit metabolism mediated by any of the following six cytochrome p450 (CYP) isoforms: 1A2, 2C9, 2C19, 2D6, 2E1 and 3A4&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d532.s6" origId="s6" text="Drug interactions caused by inhibition of P-glycoprotein-mediated drug clearance or CYP-mediated drug clearance with the listed isoforms are unlikely."><entity charOffset="44-56" id="DrugDDI.d532.s6.e0" origId="s6.p85" text="glycoprotein" type="drug"/><entity charOffset="84-87" id="DrugDDI.d532.s6.e1" origId="s6.p87" text="CYP" type="drug"/><entity charOffset="128-136" id="DrugDDI.d532.s6.e2" origId="s6.p88" text="isoforms" type="drug"/><pair e1="DrugDDI.d532.s6.e0" e2="DrugDDI.d532.s6.e1" id="DrugDDI.d532.s6.p0" interaction="false"/><pair e1="DrugDDI.d532.s6.e0" e2="DrugDDI.d532.s6.e2" id="DrugDDI.d532.s6.p1" interaction="false"/><pair e1="DrugDDI.d532.s6.e1" e2="DrugDDI.d532.s6.e2" id="DrugDDI.d532.s6.p2" interaction="false"/></sentence><sentence id="DrugDDI.d532.s7" origId="s7" text="Other than with probenecid, no specific clinical drug interaction studies have been conducted"><entity charOffset="16-26" id="DrugDDI.d532.s7.e0" origId="s7.p92" text="probenecid" type="drug"/><negationtags>Other than with probenecid, &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; specific clinical drug interaction studies have been conducted&lt;/xcope&gt;</negationtags></sentence><sentence id="DrugDDI.d532.s8" origId="s8" text="."/><sentence id="DrugDDI.d532.s9" origId="s9" text="? ?"/></document>